Naima Hanoun

Toulouse, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Detection of EGFR mutations at pM concentration in ten minutes using a microfluidic concentration and separation module.

Detection of EGFR mutations at pM concentration in ten minutes using a microfluidic concentration and separation module.

Journal: Biomedical microdevices

Published: July 15, 2025

The TRIP12's intrinsically disordered region induces chromatin condensates and interferes with nuclear processes.

The TRIP12's intrinsically disordered region induces chromatin condensates and interferes with nuclear processes.

Journal: iScience

Published: May 17, 2025

Sizing and concentration analysis of cfDNA using Biabooster technology: Results from a prospective plasma-based collection of 77 patients with locally advanced unresectable esophageal cancer.

Sizing and concentration analysis of cfDNA using Biabooster technology: Results from a prospective plasma-based collection of 77 patients with locally advanced unresectable esophageal cancer.

Journal: International journal of cancer

Published: December 05, 2024

Prognostic impact of circulating tumor DNA detection in portal and peripheral blood in resected pancreatic ductal adenocarcinoma patients.

Prognostic impact of circulating tumor DNA detection in portal and peripheral blood in resected pancreatic ductal adenocarcinoma patients.

Journal: Scientific reports

Published: May 21, 2024

The E3 ubiquitin ligase TRIP12 is required for pancreatic acinar cell plasticity and pancreatic carcinogenesis.

The E3 ubiquitin ligase TRIP12 is required for pancreatic acinar cell plasticity and pancreatic carcinogenesis.

Journal: The Journal of pathology

Published: November 14, 2023

Cytidine deaminase-dependent mitochondrial biogenesis as a potential vulnerability in pancreatic cancer cells.

Cytidine deaminase-dependent mitochondrial biogenesis as a potential vulnerability in pancreatic cancer cells.

Journal: Communications biology

Published: November 13, 2023

Preclinical development of non-viral gene therapy for patients with advanced pancreatic cancer.

Preclinical development of non-viral gene therapy for patients with advanced pancreatic cancer.

Journal: Molecular therapy. Methods & clinical development

Published: December 13, 2022

Cytidine Deaminase Resolves Replicative Stress and Protects Pancreatic Cancer from DNA-Targeting Drugs.

Cytidine Deaminase Resolves Replicative Stress and Protects Pancreatic Cancer from DNA-Targeting Drugs.

Journal: Cancer research

Published: October 12, 2022

The antitumoral activity of TLR7 ligands is corrupted by the microenvironment of pancreatic tumors.

The antitumoral activity of TLR7 ligands is corrupted by the microenvironment of pancreatic tumors.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: March 04, 2021

The E3 ubiquitin ligase TRIP12 participates in cell cycle progression and chromosome stability.

The E3 ubiquitin ligase TRIP12 participates in cell cycle progression and chromosome stability.

Journal: Scientific reports

Published: September 23, 2019

Initial Characterization of Integrase-Defective Lentiviral Vectors for Pancreatic Cancer Gene Therapy.

Initial Characterization of Integrase-Defective Lentiviral Vectors for Pancreatic Cancer Gene Therapy.

Journal: Human gene therapy

Published: January 06, 2016

First-in-man phase 1 clinical trial of gene therapy for advanced pancreatic cancer: safety, biodistribution, and preliminary clinical findings.

First-in-man phase 1 clinical trial of gene therapy for advanced pancreatic cancer: safety, biodistribution, and preliminary clinical findings.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: December 09, 2014

Showing 1-12 of 20

Last Updated: 09/26/2026